Advaxis, Inc. (NASDAQCM:ADXS) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $8.86, up from yesterday’s close by 1.03%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Does this stock stack up well when compared to its peers in the space? Let’s take a look. Advaxis, Inc. (ADXS) currently trades with a market capitalization of $353.02M.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ADXS, the company currently has $152.09M of cash on the books, which is offset by $0.00 current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $-32.83M over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -0.56 on a per share basis this quarter. Perhaps, that suggests something about why 61.10% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Advaxis, Inc. recorded a 52-week high of 16.30. It is now trading 7.53 off that level. The stock is trading 8.21 its 50-day moving average by -0.56. The stock carved out a 52-week low down at 5.21.
In recent action, Advaxis, Inc. (ADXS) has made a move of +3.63% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is outperforming the S&P 500 by 0.86, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 29.82M with 35.15% sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ADXS.